Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$34.18 0.01 (0.03%)
2/9/2010 4:00 PM

OSI Pharmaceuticals, Inc. (OSIP)

CAPS Rating:
*****

A mid-cap biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating OSIP

Add Stock to Watchlist

What the Community Thinks

Total Members

184 Outperforms
21 Underperforms
 

All-Stars

70 Outperforms
6 Underperforms
 

Wall Street

13 Outperforms
1 Underperforms
 

Members bullish on OSIP are also bullish on:

Members bearish on OSIP are also bearish on:

Ticker Tags

Research (13), Rule Breakers Universe (125), Defensive (1457), Biotechnology (220), Small Cap (1645), Growth (1902), Healthcare (711)
Suggest a tag

OSI Pharmaceuticals, Inc. At A Glance

Current Price: $34.18
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $34.17
Daily Range: $34.00 - $34.70
52-Week Range: $27.01 - $42.44
Volume: 462,482
Market Cap: $1.98B
P/E Ratio: 4.64
Compare Our Special Broker Offers!

Stock Trends

OSIP VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

2

OSI Pharmaceuticals, Inc. (OSIP)

Avatar zzlangerhans (99.64) Submitted: 4/06/09 1:43 PM

OSI has been unfairly hammered despite continuing to report strong Tarceva revenues, apparently as a result of poor overall market conditions and negative results of a phase III study which combined Tarceva and Avastin. I fail to see how the lack of improvement from adding Avastin to Tarceva will im...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3

OSI Pharmaceuticals, Inc. (OSIP)

Avatar esebeus (57.43) Submitted: 2/02/07 8:45 PM

Once Tarceva becomes obsolete around 2009, this stock is junk. Bad mgmt. Poor upside.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 21 :   1 2 3 4 5 Next »

Recs

0

 (OSIP)

Avatar Biotech2010 (40.47) Submitted: 1/26/10 8:56 PM : Outperform Start Price: $34.22 OSIP Score: 1.67

30.96

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OSIP)

Avatar HoosierJoe100 (< 20) Submitted: 1/23/10 8:01 PM : Outperform Start Price: $34.22 OSIP Score: 2.60

Innovative R&D in biopharmaceuticals for hard-to-fight respiratory diseases.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OSIP)

Avatar clawre (56.90) Submitted: 10/19/09 11:00 AM : Outperform Start Price: $32.00 OSIP Score: 9.00

Nice pharma company with good potential.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OSIP)

Avatar scoobamang (87.10) Submitted: 10/17/09 1:12 AM : Outperform Start Price: $32.02 OSIP Score: 8.44

Good fundamentals, growing revenue, near 52 week low.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OSIP)

Avatar LimoDriver1971 (90.45) Submitted: 7/29/09 10:25 AM : Outperform Start Price: $34.32 OSIP Score: -11.15

I have a sneaking suspicion that these obesity drug companies (especially the well managed ones) are going to go absolutely crazy if the health insurance reform goes through.


Especially after they outlaw being over-weight.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 21 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 14 of 14  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRBCCapMkts 86.33 07/13/09 Outperform NS $30.59+11.74%+22.00%-10.26
TrackCanaccord 86.15 02/20/09 Outperform NS $40.40-15.40%+41.83%-57.22
TrackLeerinkSwan 92.83 02/20/09 Outperform NS $38.68-11.63%+42.20%-53.83
TrackStanfordRes 85.54 11/10/08 Outperform NS $41.88-18.39%+15.59%-33.98
TrackBMOCapital 91.22 03/13/08 Outperform NS $35.54-3.83%-13.78%+9.96
TrackWellsFargo 80.02 03/03/08 Outperform NS $37.18-8.07%-16.07%+8.00
TrackUBS 87.99 01/04/08 Outperform NS $45.63-25.09%-21.72%-3.37
TrackBofASec 94.61 12/04/07 Outperform NS $47.01-27.29%-23.41%-3.89
TrackCollinsStew 68.03 11/30/07 Outperform NS $47.25-27.66%-24.59%-3.07
TrackLazardCapit < 20 10/26/07 Outperform NS $39.32-13.07%-26.23%+13.16
TrackEdwardOwens 98.91 09/30/07 Outperform NS $33.99+0.56%-26.38%+26.93 Toggle the visibility of 60-Second Pitch and replies
TrackJPMorgan 84.76 08/14/07 Outperform NS $32.00+6.81%-22.53%+29.34
TrackPiperJaff 85.79 03/22/07 Outperform NS $32.95+3.73%-21.00%+24.73
TrackCitigroup 85.92 11/08/06 Underperform NS $37.82-9.62%-17.39%-7.76

Results 1 - 14 of 14  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 625ms